Nektar Therapeutics (NKTR) financial statements (2023 and earlier)

Company profile

Business Address 455 MISSION BAY BOULEVARD SOUTH
SAN FRANCISCO, CA 94158
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7341,0621,3251,335296389309
Cash and cash equivalents251999619556056
Short-term investments7098631,2281,140291329253
Receivables2239374351620
Inventory, net of allowances, customer advances and progress billings16151311111111
Inventory16151311111111
Other current assets23181521151010
Other undisclosed current assets 43226   
Total current assets:7961,1381,4221,438327426350
Noncurrent Assets
Operating lease, right-of-use asset117126 
Property, plant and equipment61606549476671
Long-term investments and receivables6513727958357  
Long-term investments6513727958357  
Intangible assets, net (including goodwill)77777777777777
Goodwill77777777777777
Other noncurrent assets3114114
Other undisclosed noncurrent assets  134    
Total noncurrent assets:322401556712182143152
TOTAL ASSETS:1,1171,5391,9772,150509569502
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities41464629273017
Accounts payable1022196532
Accrued liabilities15101191054
Employee-related liabilities161511108186
Interest and dividends payable  44444
Deferred revenue 0 
Debt  249  35
Deferred revenue and credits191421
Contract with customer, liability614
Other liabilities  100410
Other undisclosed current liabilities446952399208
Total current liabilities:8511635482567261
Noncurrent Liabilities
Long-term debt and lease obligation126136 247245246243
Long-term debt, excluding current maturities   247245243242
Capital lease obligations  21
Operating lease, liability126136 
Liabilities, other than long-term debt319330316381
Deferred revenue and credits255871
Deferred revenue 2 
Contract with customer, liability311
Deferred rent credit   9
Other liabilities471106510
Derivative instruments and hedges, liabilities28      
Other undisclosed noncurrent liabilities195200215748999111
Total noncurrent liabilities:352346218351365409434
Total liabilities:438461572433421481496
Stockholders' equity
Stockholders' equity attributable to parent6801,0771,4051,71888886
Common stock0000000
Additional paid in capital3,5173,3893,2713,1482,2082,1111,876
Accumulated other comprehensive loss(4)(2)(1)(6)(2)(2)(2)
Accumulated deficit(2,833)(2,309)(1,865)(1,424)(2,118)(2,021)(1,867)
Total stockholders' equity:6801,0771,4051,71888886
TOTAL LIABILITIES AND EQUITY:1,1171,5391,9772,150509569502

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues1021531151,193308165231
Revenue, net667543
Cost of revenue(25)(50)(21)(24)(47)(30)(34)
Cost of goods and services sold(25)(19)(21)(24)(31)(30)(34)
Gross profit:77102931,169261135197
Operating expenses(523)(528)(533)(481)(321)(248)(226)
Operating income (loss):(446)(425)(440)688(60)(113)(29)
Nonoperating expense(77)(19)(0)(5)(36)(40)(51)
Other nonoperating income3184638522
Interest and debt expense (7)(21)(22)(22)(22)(14)
Income (loss) from continuing operations before equity method investments, income taxes:(523)(451)(461)661(118)(175)(95)
Other undisclosed income from continuing operations before income taxes 72122222214
Income (loss) from continuing operations before income taxes:(523)(444)(440)683(96)(153)(81)
Income tax expense(1)(0)(1)(1)(1)(1)(1)
Net income (loss) available to common stockholders, diluted:(524)(444)(441)681(97)(154)(81)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(524)(444)(441)681(97)(154)(81)
Other comprehensive income (loss)(2)(1)5(4)0(0)(1)
Comprehensive income (loss), net of tax, attributable to parent:(526)(446)(435)677(96)(154)(82)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: